(Q48613573)

13 February 2018

title

Ki-67 labeling is correlated with the time to recurrence in primary glioblastomas. (English)

1 reference

13 February 2018

author name string

Roland Schröder

series ordinal

1

1 reference

13 February 2018

Klaus D Feisel

series ordinal

2

1 reference

13 February 2018

Ralf-Ingo Ernestus

series ordinal

3

1 reference

13 February 2018

publication date

1 January 2002

1 reference

13 February 2018

Journal of Neuro-Oncology

published in

1 reference

13 February 2018

volume

56

1 reference

13 February 2018

issue

2

1 reference

13 February 2018

page(s)

127-132

1 reference

13 February 2018

https://scigraph.springernature.com/pub.10.1023/a:1014527929948

exact match

0 references

cites work

Prognostic significance of Ki67, p53 and epidermal growth factor receptor immunostaining in human glioblastomas.

1 reference

12 December 2020

Relationships between Ki-67 labelling index, amplification of the epidermal growth factor receptor gene, and prognosis in human glioblastomas

1 reference

12 December 2020

Regional heterogeneity in the proliferative activity of human gliomas as measured by the Ki-67 labeling index.

1 reference

12 December 2020

Meningiomas: clinical implications of a high proliferative potential determined by bromodeoxyuridine labeling

1 reference

12 December 2020

Bromodeoxyuridine labeling index in glioblastoma multiforme: relation to radiation response, age, and survival.

1 reference

12 December 2020

Proliferating cell nuclear antigen and Ki-67 immunohistochemistry of oligodendrogliomas with special reference to prognosis.

1 reference

12 December 2020

Image cytometric measurement of nuclear proliferation markers (MIB-1, PCNA) in astrocytomas. Prognostic significance.

1 reference

12 December 2020

MIB-1 proliferation index predicts survival among patients with grade II astrocytoma

1 reference

12 December 2020

Proliferative activity and prognosis of low-grade astrocytomas.

1 reference

12 December 2020

Use of MIB-1 (Ki-67) immunoreactivity in differentiating grade II and grade III gliomas.

1 reference

12 December 2020

Assessment of cell proliferation in pathology--what next?

1 reference

12 December 2020

Prognostic factors in oligodendroglioma.

1 reference

12 December 2020

Cell proliferation patterns in the diagnosis of astrocytomas, anaplastic astrocytomas and glioblastoma multiforme: a Ki-67 study

1 reference

12 December 2020

Prognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA, and S-phase fraction using archival paraffin-embedded samples

1 reference

12 December 2020

The relationship between Ki-67 labeling and mitotic index in gliomas and meningiomas: demonstration of the variability of the intermitotic cycle time.

1 reference

12 December 2020

Prognostic value of the proliferation-related antigen Ki-67 in oligodendrogliomas.

1 reference

12 December 2020

Prognostic significance of bromodeoxyuridine labeling in primary and recurrent glioblastoma multiforme.

1 reference

12 December 2020

[Cytophotometric investigations in recurrent gliomas: correlation of DNA-parameters with WHO-grade, proliferation index and recurrence-free interval]

1 reference

12 December 2020

Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours

1 reference

12 December 2020

Ki-67 antigen expression as a prognostic factor in primary and recurrent astrocytomas.

1 reference

12 December 2020

Proliferative potential and prognostic evaluation of low-grade astrocytomas

1 reference

12 December 2020

Prognostic value of the expression of tumor suppressor genes p53, p21, p16 and prb, and Ki-67 labelling in high grade astrocytomas treated with radiotherapy.

1 reference

12 December 2020

The interaction of growth rates and diffusion coefficients in a three-dimensional mathematical model of gliomas.

1 reference

12 December 2020

Prognostic significance of Ki-67 proliferation index in supratentorial fibrillary astrocytic neoplasms

1 reference

12 December 2020

Predicting the recurrence of ependymomas from the bromodeoxyuridine labeling index

1 reference

12 December 2020

Prognostic implications of the bromodeoxyuridine labeling index of human gliomas

1 reference

12 December 2020

The prognostic significance of Ki-67 labeling indices for oligodendrogliomas.

1 reference

12 December 2020

Retinoblastoma protein expression and MIB-1 correlate with survival of patients with malignant astrocytoma.

1 reference

12 December 2020

Analysis of proliferation and apoptosis in brain gliomas: prognostic and clinical value

1 reference

12 December 2020

Prognostic indicators in a range of astrocytic tumours: an immunohistochemical study with Ki-67 and p53 antibodies.

1 reference

12 December 2020

Ki-67 (clone MIB-1) proliferation index in recurrent glial neoplasms: no prognostic significance

1 reference

12 December 2020

Statistical modelling in analysis of prognosis in glioblastoma multiforme: a study of clinical variables and Ki-67 index

1 reference

12 December 2020

Cellular proliferation in pilocytic and diffuse astrocytomas.

1 reference

12 December 2020

Prognostic implication of histopathological, immunohistochemical and clinical features of oligodendrogliomas: a study of 89 cases.

1 reference

12 December 2020

A comparison of the predictive power for survival in gliomas provided by MIB-1, bromodeoxyuridine and proliferating cell nuclear antigen with histopathologic and clinical parameters.

1 reference

12 December 2020

Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas.

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1014527929948

1 reference

13 February 2018

Dimensions Publication ID

1019692547

0 references

1 reference

13 February 2018